About

Nick was the Managing Editor for growthbusiness.co.uk when it was owned by Vitesse Media, before moving on to become Head of Investment Group and Editor at What Investment and thence to Head of Intermediary Communications at The Association of Investment Companies (AIC).

Venture Capital Funding

Top 10 equity providers for UK companies

Find out who the biggest equity investors are in UK companies, ranked in order of number of deals.

News

Canaccord Adams buys Intelli Partners

Canaccord Adams, a UK investment bank and subsidiary of Canacord Capital, has agreed to acquire Edinburgh-based Intelli Partners for an undisclosed sum.

Entrepreneurs

Chris Murphy on relaunching a business

Chris Murphy set up his marketing company, Fox Murphy, in 1997 and relaunched the business as Balloon Dog last year. But changing the business to give it a much-needed lift wasn't easy

News

NVM celebrates lucrative exit

Medical diagnostics company DXS has been sold for as much as $130 million, leading to a ‘record exit’ for NVM Private Equity.

News

ReneSola acquires Dynamic Green

China-based manufacturer of solar products ReneSola has agreed to acquire rival Dynamic Green Energy in a share and cash deal.

Venture Capital Funding

A crisis in venture capital

Cash-burning portfolio companies, dissent among co-investors and a tepid response to fundraisings are making life difficult for venture capital firms. We speak to key players about the industry's future.

Technology

Green shoots or wishful thinking?

Dealmakers discuss the supposed economic upturn 

News

Technis joins PLUS

Technology development company Technis International comes to PLUS-quoted on Thursday through an introduction handled by Bridge Hall Stockbrokers.

Growth Planning

My first £10 million – Three entrepreneurs’ routes to success

Hitting those double digits is no easy task, as these three entrepreneurs can testify.

News

Steve Nicholson: Overhauling The Cloud

Wi-fi broadband provider The Cloud has been through a radical overhaul in the past couple of years.

News

Goldshield discusses potential rival offer

With AIT’s £162 million ‘agreed’ bid on the table, Goldshield Group directors are discussing a potential rival offer from its management.

News

Allergy shaves losses

Allergy Therapeutics expresses optimism over US prospects for its hay fever vaccine after cutting annual losses 43 per cent to £11.4 million.